International Consensus For The Dosing Of Corticosteroids In Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis.
Nathalie E ChalhoubScott E WenderferDeborah M LevyKelly Rouster-StevensAggarwal AmitaSonia I SavaniNatasha M RuthThaschawee ArkachaisriTingting QiuAngela MerrittKaren OnelBeatrice GoilavRaju P KhubchandaniJianghong DengAdriana Rodrigues FonsecaStacy P ArdoinCoziana CiurtinOzgur KasapcopurMarija JelusicAdam M HuberSeher SenerMarisa S Klein-GitelmanSimone AppenzellerAndré CavalcantiLampros FotisLim Sern ChinRodrigo M SilvaJulia Ramírez-MiramontesNatalie L RosenwasserClaudia Saad-MagalhaesDieneke Schonenberg-MeinemaChristiaan ScottClovis A SilvaSandra EncisoMaria T TerreriAlfonso-Ragnar Torres-JimenezMaria TrachanaSulaiman M Al-MayoufPrasad DevarajanBin HuangHermine I Brunnernull nullPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
The SSR represents an international consensus on CS dosing for use in patients with cSLE and proliferative LN. The SSR is anticipated to be used for clinical care and standardize CS-dosage during clinical trials.